ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag universal flu vaccine culture

a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
Flu vaccines: Looking beyond eggs
Ishani Ganguli | Mar 30, 2006 | 4 min read
Timeliness and risks to eggs in avian flu pandemic lead companies to seek other production methods
Illustration of viruses represented with different colors overlapping each other.
What Happens When You Catch More than One Virus?
Alejandra Manjarrez, PhD | Dec 7, 2022 | 8 min read
The “tripledemic” shines a spotlight on viral interference, in which one infection can block another.
3D rendered images of three T cell
T Cells Ward Off Aging with Help from Their Friends
Natalia Mesa, PhD | Sep 16, 2022 | 5 min read
Immune cells deliver packages of telomeres to T cells, helping them retain their virus-fighting function over time, research suggests.
Can biotech tackle swine flu?
Bob Grant | Apr 26, 2009 | 3 min read
As reported cases of swine flu continue to accumulate (as of today, 40 had been linkurl:reported;http://www.cdc.gov/swineflu/index.htm in the US) and mainstream media outlets dust off their foreboding music tracks and positively scary taglines, a biotechnology company in Maryland says that its approach may speed development of a successful vaccine. Influenza A/South Carolina/1918 (H1N1) VLPsImage: Novavax, Inc.Researchers at Novavax have been developing vaccines for the H5N1 strain of avian flu
Fighting Flu
Abby Olena, PhD | Dec 14, 2013 | 3 min read
Researchers link host glucose metabolism with severity of influenza infection.
Man with white hair sits in front of a world map
Famed Pathologist Johan Hultin Dies at 97
Lisa Winter | Mar 2, 2022 | 3 min read
Hultin’s work helped identify the virus behind the 1918 flu pandemic.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020 | 9 min read
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Week in Review: October 21–25
Tracy Vence | Oct 25, 2013 | 4 min read
PubMed launches Commons; measuring HIV’s latent reservoir; immune-related pathway variation in genome, microbiome; rapamycin and flu vaccines; grasshopper mice resistant to pain
Building Vaccine Consensus
Stephen Pincock | Nov 1, 2007 | 7 min read
By Stephen PincockBIOBUSINESSWhen Klaus Stöhr left the World Health Organization to take a job at the Swiss drug giant Novartis in February, there were some who questioned whether the most prominent figure in the global fight against avian influenza had forsaken public health for profit margins. "I don't see why this should be good news," wrote one blogger with the moniker "gsgs" on a site devoted to pandemic flu soon after t

Run a Search

ADVERTISEMENT